secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2023-11-27T23:59:59+00:00
Accession:  0001728117-23-000151
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio adopts 2023 inducement plan reserving 6.76M shares for new hires and amends bylaws
--------------------------------------------------------------------------------

- Board approved 2023 Inducement Plan with 6,762,279 common shares reserved for grants to new employees as material inducement to hire.
- Plan substantially similar to 2019 Incentive Award Plan but no ISOs; adopted without stockholder approval per NASDAQ Rule 5635(c)(4).
- Bylaws amended effective Nov 27, 2023 to address universal proxy rules under SEC Rule 14a-19 and enhance disclosure for stockholder nominations.
- Amendments also include technical, modernizing and clarifying changes to the bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811723000151/0001728117-23-000151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811723000151/goss-20231120.htm
  HTML page:      https://secwatch.observer/filing/0001728117-23-000151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer